US Stock MarketDetailed Quotes

MTNB Matinas BioPharma

Watchlist
  • 0.5200
  • -0.0201-3.72%
Close Mar 31 16:00 ET
  • 0.5200
  • 0.00000.00%
Post 17:34 ET
2.65MMarket Cap-0.11P/E (TTM)

Matinas BioPharma Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Matinas BioPharma Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 1 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 0.000--
--2024/Q4-- / 0.000--
--2024/Q30.000 / 0.000--
Aug 14, 20242024/Q20.000 / 0.000--
May 9, 20242024/Q10.000 / 0.000--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 0.000--
--2024/Q4-- / 0.000--
--2024/Q30.000 / 0.000--
Aug 14, 20242024/Q20.000 / 0.000--
May 9, 20242024/Q10.000 / 0.000--

Unlock Free Earnings Estimates

Matinas BioPharma Earnings Reports

  • Matinas BioPharma | 10-Q: Q3 2024 Earnings Report

    Nov 13, 2024 17:23 ET

  • Matinas BioPharma | 10-Q: Q2 2024 Earnings Report

    Aug 14, 2024 16:53 ET

  • Matinas BioPharma | 8-K: Matinas BioPharma Reports Second Quarter 2024 Financial Results and Provides a Business Update

    Aug 14, 2024 16:53 ET

  • Matinas BioPharma | 8-K: Matinas BioPharma Reports First Quarter 2024 Financial Results and Provides a Business Update

    May 9, 2024 16:14 ET

    • Read more

    Market Insights
    Best Growth Stocks Best Growth Stocks

    Spot stocks with huge growth potential and solid financial standing. Spot stocks with huge growth potential and solid financial standing.

    Symbol Mini Chart % Chg
    Precision Drilling
    PDS
    +2.78%
    Lantheus
    LNTH
    +1.50%
    eBay
    EBAY
    +0.85%
    DexCom
    DXCM
    +0.81%
    Collegium Pharmaceutical
    COLL
    +0.47%

    Unlock the Full List